Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowPress Release Apr 29 2026
29m agoUBS reports USD 3.0bn net profit and 16.8% RoCET1 in 1Q26 driven by strong client activity and flows; on track to complete integration by year-end (Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules)
57m agoe.l.f. Cosmetics Joins the International Dance League as Founding Partner to Put Dancers Center Stage
1h agoTDG Gold Appoints Paul Geddes as Senior Vice-President Business Development and Strategy
1h agoMeryllion Resources Announces New Non-Brokered LIFE Financing
Revelation Biosciences Inc logo

Revelation Biosciences Inc

About

Revelation Biosciences Inc (NASDAQ:REVB) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 26 2026
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
Jan 26 2026
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
Jan 23 2026
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
Jan 21 2026
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
Jan 14 2026
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

Financials

Revenue
$0
Market Cap
$4.65 M
EPS
-23.95

Community Chat

Ask AI

6ix6ix